In addition, Pip treatment can prevent obesity and improve lipid metabolism by regulating adipose tissue expansion (ATE) related genes Sfrp5, MEST, PTRF/Cavin1 [47]. This evidence concerns the gene CAVIN1 and obesity due to melanocortin 4 receptor deficiency.